Trade Desk’s Technological Innovation Drives Dominance: Analyst Foresees Revenue Surge In Coming Years
William Blair analyst Ralph Schackart initiated coverage on The Trade Desk Inc (NASDAQ: TTD)
Benzinga’s Top Ratings Upgrades, Downgrades For September 6, 2023
Upgrades According to Morgan Stanley, the prior rating for First Solar Inc (NASDAQ:FSLR) was changed from Underweight to…
Analyst Applauds Automatic Data Processing Strong Fundamentals, But Keeps An Eye On Macro Headwinds
RBC Capital Markets analyst Ashish Sabadra initiated coverage on Automatic Data Processing Inc (NASDAQ: ADP) at Sector Perform with a
NSA’s Asset Growth And Rising Interest Rates: Analyst Sets $35 Price Target Amid Secondary Market Strength
BMO Capital Markets analyst Juan C.
Paychex’s Strong Fundamentals Vs. Market Headwinds: Analyst Initiates With Sector Perform Rating
RBC Capital Markets analyst Ashish Sabadra initiated coverage on Paychex Inc (NASDAQ: PAYX) at a Sector Perform rating
Duckhorn Faces Margin Challenges Despite Distribution Growth, Analyst Cites Macro Sensitivity
BMO Capital analyst Andrew Strelzik initiated the coverage on The Duckhorn Portfolio, Inc. (NYSE: NAPA) with a
Pyxis Oncology M&A Spotlight Signals Potential Growth Amidst Competitive ADC Landscape: Analyst
RBC Capital Markets has initiated coverage on Pyxis Oncology Inc (NASDAQ: PYXS) with an Outperform rating and a
Benzinga’s Top Ratings Upgrades, Downgrades For September 5, 2023
Upgrades For Belden Inc (NYSE:BDC), Goldman Sachs upgraded the previous rating of Neutral to Buy. Belden earned $1.91…
Benzinga’s Top Ratings Upgrades, Downgrades For September 1, 2023
Upgrades According to Guggenheim, the prior rating for Eos Energy Enterprises Inc (NASDAQ:EOSE) was changed from Neutral to…
Biotech Stock Crinetics Pharmaceuticals Positioned For Success In Chronic Endocrine Disorder Treatment, Says Analyst
Oppenheimer initiated coverage on Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) with an Outperform rating